: Provides access to advanced diagramming, unlimited boards, and private workspace features.
After two weeks of rigorous testing, our team transitioned to a paid plan. Here is why the trial converted us: miro trial
The (Multicentre Randomized Controlled Phase III Trial) is a landmark medical study that established the hybrid minimally invasive esophagectomy (HMIE) as a superior alternative to traditional open surgery for patients with esophageal cancer. Overview of the MIRO Trial : Provides access to advanced diagramming, unlimited boards,
The hybrid group experienced a significantly lower rate of major complications (36%) compared to the open surgery group (64%). : Provides access to advanced diagramming